KMT2A and leukemia: Of the thieno[3,2-b]pyrrole-5-carboxamides, novel reversible inhibitors of KDM1A, that showed a remarkable anti-clonogenic cell growth effect on MLL-AF9 human leukemia cells (59) (Table 1).